Halipa, Jaharia .
HRN: 18-69-41 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/03/2025
CEFUROXIME 1.5GM (VIAL)
12/03/2025
12/10/2025
IV
1.5g LD Then 750
Q8
Ltcs
Checking Final Appropriateness
Indication: ProphylaxisEmpiric Type of Infection: Urinary TractIntra-abdominalReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes